advertisement

Topcon

Abstract #23854 Published in IGR 11-2

Second Ahmed valve insertion in the same eye

Smith M; Buys YM; Trope GE
Journal of Glaucoma 2009; 18: 336-340


PURPOSE: To examine the results of same-eye second Ahmed glaucoma drainage device (GDD) insertion in eyes with refractory glaucoma despite previous Ahmed GDD insertion and maximal tolerated medical therapy. METHODS: Noncomparative retrospective case series. RESULTS: Twenty-one patients who had undergone 2 GDD surgeries in the same eye were identified. Following chart review, 19 patients had follow-up of at least 1 year and were included in the analysis. All surgeries involved Ahmed valves. The mean drop in intraocular pressure (IOP) at 12 months and at final follow-up was 8 (43%) and 7.9 mm Hg (42%), respectively. The mean number of glaucoma medications used postoperatively (2.4 at 12 mo and 2.6 at final follow-up) was significantly less than preoperatively (4.1). Although the mean visual acuity was poorer postoperatively, this did not reach statistical significance. Sixteen of the 19 patients (84.2%) were defined as complete or partial success, as they achieved IOP of >/=5 and ≤21 mm Hg and >/=20% decrease on preoperative IOP with or without glaucoma drops. Three patients were considered complete failures at 12 months and final follow-up. There were no significant intraoperative complications. One patient (5.3%) required anterior chamber reformation on day 1 postoperatively. One patient (5.3%) suffered a decrease in vision from 20/70 preoperatively to counting fingers postoperatively owing to corneal decompensation. CONCLUSIONS: Second Ahmed GDD surgery seems to be a safe and effective option when IOP remains uncontrolled despite previous GDD implantation.

Department of Ophthalmology and Visual Sciences, Toronto Western Hospital, University of Toronto, Ontario, Canada. mic.smith@utoronto.ca


Classification:

12.8.2 With tube implant or other drainage devices (Part of: 12 Surgical treatment > 12.8 Filtering surgery)



Issue 11-2

Change Issue


advertisement

Oculus